A high prevalence of hyperinsulinemia and IR was observed in Spanish patients carrying a mutation in the PBGD gene who had either stable (without clinical outcomes associated with acute porphyria) or asymptomatic disease (AIP-ASHE). This evidence concerns the gene HMBS and hepatic porphyria.